Tom Rönnlund

Position: CEO
Date of birth: 26.11.1972
Employment history:
- 2015-: CEO Navamedic ASA 

Tom Rönnlund has nearly 20 years’ experience working in sales, marketing and management positions in the life science industry. Prior to joining Navamedic Tom was IMS Health's General Manager for the Nordic and Baltic region. Previous experience includes being Country Manager in Sweden for Bristol-Myers Squibb, Business Unit Director at Eli Lilly Sweden and Denmark. Tom Rönnlund holds a Masters degree in Business Administration and Economics from Stockholm University.

Mr. Rönnlund holds 40 000 shares in the Company.

Bjørn Lindholt

Bjørn Lindholt

Position: Chief Financial Officer (CFO)
Date of birth: 11.02.1955
Master of Business and Marketing, Oslo School of Management (BI)

Employment history:
- 2001-2010: CFO Profdoc ASA
- 1994-2001: CFO NetCenter AS/Merkantildata ASA
- 1993-1994: Management Consultant Oslo Consulting Group AS  
- 1989-1993: CFO/ Country Manager Valmet Automation AS
- 1985-1989: Vice President Bank of Oslo
- 1984-1985: Country Manager Union Bank of Norway
- 1982-1984: Head of business Hospital sector ISS Norway
- 1981-1982: Trainee Finance dep. Cons. Fertilizers Inc. Australia

Mr Lindholt holds 88,000 shares in the Company, directly 54,000 and indirectly 34,000.

Per-Anders ElvertrøPer-Anders Elvertrø

Position: Chief Commercial Officer
Head of Regulatory Affairs & Drug Safety
Date of birth: 07.06.1974
MSc Biology, Norwegian University of Science and Technology, Trondheim.

Employment history:
- 2009-2010: Head of Regulatory Competence Center, Sandoz GmbH, Munich, Germany
- 2009:           Nordic Regulatory Affairs Manager, Sandoz A/S, Copenhagen, Denmark
- 2008-2009: Regulatory Affairs Manager, Sandoz Pty Ltd, Sydney, Australia 
- 2007-2008: Nordic Regulatory Affairs Manager, Sandoz AS, Oslo, Norway
- 2005-2007: Regulatory Affairs Manager, Sandoz AS, Oslo, Norway
- 2003-2007: Regulatory Affairs Manager, Hexal AS, Oslo, Norway
- 2001-2003: Key Account Manager, Hexal AS, Oslo, Norway

Mr. Elvertrø holds 30 000 shares in the Company.

Magnus Emmoth 

Position: CEO Observe Medical Int.
Date of birth: 1966
MBA from Kellogg School of Management, Chicago USA.

Magnus Emmoth is one of OM’s three founders. Magnus Emmoth has extensive experience from a career that, as well as spanning the finance sector, also includes leading positions at a number of medtech companies. His experience ranges from early-stage business development to management positions within larger business concerns. Magnus was among other also responsible for the urological division in the Nordics at Covidien.